ESTROGEN RECEPTOR POSITIVE TUMOR

Clinical trials for ESTROGEN RECEPTOR POSITIVE TUMOR explained in plain language.

Never miss a new study

Get alerted when new ESTROGEN RECEPTOR POSITIVE TUMOR trials appear

Sign up with your email to follow new studies for ESTROGEN RECEPTOR POSITIVE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug trial targets Hormone-Driven uterine cancers

Disease control Not yet recruiting

This study is testing a drug called elacestrant for people with advanced uterine sarcoma that is fueled by estrogen. The goal is to see if the drug can shrink or control the cancer by blocking estrogen's effects. About 30 participants with specific types of advanced uterine sarco…

Matched conditions: ESTROGEN RECEPTOR POSITIVE TUMOR

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ESTROGEN RECEPTOR POSITIVE TUMOR

Get alerted when new ESTROGEN RECEPTOR POSITIVE TUMOR trials appear

New drug trial targets Hormone-Driven uterine cancers